Perbedaan Chitose Internasional Tbk. dan UBC Medical Indonesia Tbk.: Chitose Internasional Tbk. diperdagangkan di Rp166 (kapitalisasi pasar 166 M, volume 24 jam 77,9 rb), sedangkan UBC Medical Indonesia Tbk. diperdagangkan di Rp146 (kapitalisasi pasar 584,6 M, volume 24 jam 817,3 rb). Perbedaan utamanya: UBC Medical Indonesia Tbk. jauh lebih besar — sekitar 3,5× kapitalisasi pasar Chitose Internasional Tbk., dan UBC Medical Indonesia Tbk. lebih aktif diperdagangkan (817,3 rb vs 77,9 rb). Mana yang lebih baik tergantung tujuan investasimu.
| CINT | LABS | |
|---|---|---|
Kapitalisasi Pasar | 166 M | 584,6 M |
Volume | 77,9 rb | 817,3 rb |
Lot | 779 | 8,17 rb |
Perputaran | 12,99 jt | 120,01 jt |
Harga Rata-rata | 166,74 | 146,84 |
Nilai Transaksi | 12,99 jt | 120,01 jt |
Harga Ekuilibrium Indikatif | 168 | 146 |
Volume Ekuilibrium Indikatif | 16 | 59 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Chitose Internasional Tbk (the Company) formerly PT Chitose Indonesia Manufacturing was established based on Notarial Deed No. 21 dated June 15, 1978 of Widyanto Pranamihardja, S.H., notary in Bandung. The name was changed to PT Chitose Internasional on October 4, 2013. The company with brand Chitose has a high market share in all product categories, including folding chair, hotel, restaurant, food coourt, office and working chair and chair school.
Selengkapnya di halaman CINT →PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Selengkapnya di halaman LABS →